Cardiol Therapeutics マネジメント
マネジメント 基準チェック /14
Cardiol Therapeuticsの CEO はDavid Elsleyで、 Jan2017年に任命され、 の在任期間は 7.83年です。 の年間総報酬はCA$ 748.10Kで、 70.2%給与と29.8%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の1.51%を直接所有しており、その価値はCA$ 2.76M 。経営陣と取締役会の平均在任期間はそれぞれ3.9年と2.8年です。
主要情報
David Elsley
最高経営責任者
CA$748.1k
報酬総額
| CEO給与比率 | 70.2% |
| CEO在任期間 | 7.8yrs |
| CEOの所有権 | 1.5% |
| 経営陣の平均在職期間 | 3.9yrs |
| 取締役会の平均在任期間 | 2.8yrs |
経営陣の近況
Recent updates
We're Not Very Worried About Cardiol Therapeutics' (TSE:CRDL) Cash Burn Rate
Sep 12
Is Cardiol Therapeutics (TSE:CRDL) In A Good Position To Deliver On Growth Plans?
May 01Will Cardiol Therapeutics (TSE:CRDL) Spend Its Cash Wisely?
Jan 06Is Cardiol Therapeutics (TSE:CRDL) In A Good Position To Invest In Growth?
Sep 13We Think Cardiol Therapeutics (TSE:CRDL) Needs To Drive Business Growth Carefully
May 24We Think Cardiol Therapeutics (TSE:CRDL) Can Afford To Drive Business Growth
Jan 20We Think Cardiol Therapeutics (TSE:CRDL) Can Afford To Drive Business Growth
Aug 10We're Not Worried About Cardiol Therapeutics' (TSE:CRDL) Cash Burn
Apr 17Here's Why We're Not Too Worried About Cardiol Therapeutics' (TSE:CRDL) Cash Burn Situation
Dec 09We Think Cardiol Therapeutics (TSE:CRDL) Needs To Drive Business Growth Carefully
Aug 19Here's Why We're Not Too Worried About Cardiol Therapeutics' (TSE:CRDL) Cash Burn Situation
Apr 18Companies Like Cardiol Therapeutics (TSE:CRDL) Are In A Position To Invest In Growth
Jan 03CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -CA$36m |
| Jun 30 2024 | n/a | n/a | -CA$29m |
| Mar 31 2024 | n/a | n/a | -CA$30m |
| Dec 31 2023 | CA$748k | CA$525k | -CA$28m |
| Sep 30 2023 | n/a | n/a | -CA$28m |
| Jun 30 2023 | n/a | n/a | -CA$30m |
| Mar 31 2023 | n/a | n/a | -CA$29m |
| Dec 31 2022 | CA$654k | CA$525k | -CA$31m |
| Sep 30 2022 | n/a | n/a | -CA$30m |
| Jun 30 2022 | n/a | n/a | -CA$32m |
| Mar 31 2022 | n/a | n/a | -CA$32m |
| Dec 31 2021 | CA$1m | CA$455k | -CA$32m |
| Sep 30 2021 | n/a | n/a | -CA$35m |
| Jun 30 2021 | n/a | n/a | -CA$30m |
| Mar 31 2021 | n/a | n/a | -CA$27m |
| Dec 31 2020 | CA$517k | CA$450k | -CA$21m |
| Sep 30 2020 | n/a | n/a | -CA$14m |
| Jun 30 2020 | n/a | n/a | -CA$13m |
| Mar 31 2020 | n/a | n/a | -CA$13m |
| Dec 31 2019 | CA$450k | CA$450k | -CA$14m |
| Sep 30 2019 | n/a | n/a | -CA$20m |
| Jun 30 2019 | n/a | n/a | -CA$21m |
| Mar 31 2019 | n/a | n/a | -CA$19m |
| Dec 31 2018 | CA$713k | CA$363k | -CA$16m |
報酬と市場: Davidの 総報酬 ($USD 535.08K ) は、 Canadian市場 ($USD 169.37K ) の同規模の企業の平均を上回っています。
報酬と収益: Davidの報酬は増加しましたが、会社は利益を上げていません。
CEO（最高経営責任者
David Elsley
7.8yrs
在職期間
CA$748,100
報酬
Mr. David G. Elsley, MBA, has been the President, Chief Executive Officer and Director of Cardiol Therapeutics Inc since January 19, 2017. Mr. Elsley is a business leader with a proven track record of deve...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| President | 7.8yrs | CA$748.10k | 1.51% CA$ 2.8m | |
| CFO, Corporate Secretary & Director | 6.3yrs | CA$294.80k | 0.14% CA$ 251.9k | |
| Chief Operating Officer | 3.9yrs | CA$515.90k | 0.038% CA$ 68.7k | |
| Chief Medical Officer & Head of Research & Development | 3.7yrs | CA$746.56k | 0.56% CA$ 1.0m | |
| Investor Relations | no data | データなし | データなし | |
| Vice President of Corporate Development | less than a year | データなし | データなし |
3.9yrs
平均在職期間
経験豊富な経営陣: CRDLの経営陣は 経験豊富 であると考えられます ( 3.9年の平均在職年数)。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| President | 7.8yrs | CA$748.10k | 1.51% CA$ 2.8m | |
| CFO, Corporate Secretary & Director | 2.5yrs | CA$294.80k | 0.14% CA$ 251.9k | |
| Independent Director | 4.9yrs | CA$60.00k | 0.18% CA$ 326.3k | |
| Independent Director | 2.7yrs | CA$76.92k | 0.13% CA$ 229.0k | |
| Independent Director | 6.9yrs | CA$58.00k | 0.58% CA$ 1.1m | |
| Independent Director | 3.2yrs | CA$71.52k | 1.07% CA$ 2.0m | |
| Member of Scientific Advisory Board | 2.8yrs | データなし | データなし | |
| Member of Scientific Advisory Board | 2.8yrs | データなし | データなし | |
| Independent Director | 2.5yrs | CA$82.32k | 0.15% CA$ 274.8k | |
| Independent Chairman | 6.3yrs | CA$112.68k | 0.28% CA$ 505.0k | |
| Member of Scientific Advisory Board | 2.8yrs | データなし | データなし |
2.8yrs
平均在職期間
56yo
平均年齢
経験豊富なボード: CRDLの 取締役会 は 経験豊富 ではない ( 2.8年の平均在任期間) ため、新しい取締役会が必要であると考えられます。